Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD209 | Q9NNX6 | 2/20 | 0.50 |
| ▸ | ENGASE | Q8NFI3 | 1/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 7/20 | 0.43 |
| ▸ | LGALS8 | O00214 | 3/20 | 0.43 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.40 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.40 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.40 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.40 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14199396 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL13659933 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL11220673 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL14227992 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL17830236 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL11220668 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL13290316 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL6815714 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL5525028 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 | |
| SCHEMBL14227913 | 0.89 | CD209 (0.60) | CD209ENGASELGALS8LGALS3LGALS4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1938 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122030617-A | Composition for improving stool consistency or frequency of infants or young children | 雀巢产品有限公司 | 2026-05-15 | — | — | CN | claimed |
| WO-2026101234-A1 | PHOTOCATALYST COMPRISING METHANE MONOOXYGENASE HYDROXYLASE AND XANTHENE-BASED PHOTO HARVESTER | 건국대학교 산학협력단 | 2026-05-15 | — | — | WO | claimed |
| CN-122030606-A | DHA composite nutritional preparation special for infants and preparation method thereof | 太原郫畅科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122004473-A | Lactobacillus plantarum BL-17 for relieving atopic dermatitis and application thereof | 东北农业大学 | 2026-05-12 | — | — | CN | claimed |
| US-12584101-B2 | Compositions and method of use for H5 competent Bifidobacterium longum subsp. Infantis | INFINANT HEALTH, INC. (US) | 2026-03-24 | — | — | US | claimed |
| CN-120617323-B | Application of akkermansia muciniphila and breast milk oligosaccharide in preparing depression relieving products | 东北农业大学 | 2026-02-27 | — | — | CN | claimed |
| US-20250388855-A1 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | Infinant Health, Inc (US) | 2025-12-25 | — | — | US | claimed |
| US-20250344737-A1 | NUTRITIONAL COMPOSITIONS WITH MFGM AND CERTAIN HUMAN MILK OLIGOSACCHARIDES AND USES THEREOF | PBM Nutritionals, LLC (US) | 2025-11-13 | — | — | US | claimed |
| US-20250283130-A1 | GLYCOSYLTRANSFERASE DEFICIENT CORYNEBACTERIUM FOR THE PRODUCTION OF FUCOSYLLACTOSE | GALAB LABORATORIES GMBH (DE) | 2025-09-11 | — | — | US | claimed |
| EP-4025072-B1 | PROCESS FOR REMOVING AN ANTIFOAM AGENT FROM A SOLUTION COMPRISING A HUMAN MILK OLIGOSACCHARIDE AND RELATED COMPOSITIONS | INBIOSE NV (BE) | 2025-08-20 | — | — | EP | claimed |
| CN-114173579-A | Composition for inducing satiety | 菲仕兰坎皮纳荷兰公司 | 2022-03-11 | — | — | CN | claimed |
| CN-114145353-A | Formula milk powder capable of improving intestinal microenvironment health and preparation method and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-114145356-A | Formula milk powder capable of improving immune response and preparation method and application thereof | 内蒙古伊利实业集团股份有限公司 | 2022-03-08 | — | — | CN | claimed |
| CN-114128767-A | Milk protein partially hydrolyzed hypoallergenic infant formula containing breast milk oligosaccharides | 内蒙古伊利实业集团股份有限公司 | 2022-03-04 | — | — | CN | claimed |
| CN-114032261-A | Method for obtaining high-purity fucosyllactose by degrading lactose in fermentation liquor | 中国科学院合肥物质科学研究院 | 2022-02-11 | — | — | CN | claimed |
| CN-114015714-A | Mutant microorganisms resistant to lactose killing | 因比奥斯公司 | 2022-02-08 | — | — | CN | claimed |
| CN-114009510-A | Hypoallergenic infant goat milk-based formula milk powder and preparation method thereof | 北安宜品努卡乳业有限公司 | 2022-02-08 | — | — | CN | claimed |
| WO-2022026483-A2 | MICROBIOME MEDIATED INDUCTION OF IMMUNE TOLERANCE AND RESOLUTION OF INFLAMMATION | Evolve Biosystems, Inc. (US) | 2022-02-03 | — | — | WO | claimed |
| CN-114007434-A | Nutritional composition | 森永乳业株式会社 | 2022-02-01 | — | — | CN | claimed |
| US-20220023418-A1 | FUCOSYLLACTOSE AS BREAST MILK IDENTICAL NON-DIGESTIBLE OLIGOSACCHARIDE WITH NEW FUNCTIONAL BENEFIT | N.V. NUTRICIA (NL) | 2022-01-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12584101-B2 | Compositions and method of use for H5 competent Bifidobacterium longum subsp. Infantis | FUT5, VNN1, FUT8 | CD209 1946/4885ENGASE 19/4885PTPN1 4709/4885 |
| US-20250388855-A1 | COMPOSITIONS AND METHOD OF USE FOR H5 COMPETENT BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS | MRPL21, VNN1, NT5M | CD209 2434/4885ENGASE 320/4885PTPN1 4155/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.